Details for New Drug Application (NDA): 202795
✉ Email this page to a colleague
NDA 202795 describes NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE, which is a drug marketed by Altaire Pharms Inc and Rising and is included in two NDAs. It is available from one supplier. Additional details are available on the NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE profile page.
The generic ingredient in NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE is naphazoline hydrochloride; pheniramine maleate. There are eight drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the naphazoline hydrochloride; pheniramine maleate profile page.
The generic ingredient in NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE is naphazoline hydrochloride; pheniramine maleate. There are eight drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the naphazoline hydrochloride; pheniramine maleate profile page.
Summary for 202795
| Tradename: | NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE |
| Applicant: | Rising |
| Ingredient: | naphazoline hydrochloride; pheniramine maleate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.025%;0.3% | ||||
| Approval Date: | Jan 24, 2013 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
